PATENT CLAIM ANALYSIS

Application Number: 16295482
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["424", "400000"]

Abstract:
Provided herein are stable lisinopril oral liquid formulations. Also provided herein are methods of using lisinopril oral liquid formulations for the treatment of certain diseases including hypertension, heart failure and acute myocardial infarction.

Claim (Index 11):
A method of treating heart failure in a subject comprising administering to that subject a therapeutically effective amount of a stable oral liquid formulation, comprising:\n (i) about 1 mg/ml lisinopril or a pharmaceutically acceptable salt or solvate thereof; (ii) a sweetener; (iii) a buffer comprising citric acid and sodium citrate; (iv) a preservative selected from the group consisting of sodium benzoate, benzoic acid, sorbic acid, methylparaben, propylparaben, and salts thereof; and (v) water; wherein the formulation is stable at about 25\u00b15\u00b0 C. for at least 6 months.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.28571
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15805934', '15268095', '16053164', '15483691', '14934752']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7629063090869025
- 35 USC 102 Novelty (BERT): 0.5582843077393208
- Combined Prediction Score: 0.7424441089521443
- Mean Citation Score: 406.204134
- Max Citation Score: 429.55508
- Similarity Product: 405.0473540911697

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test